Literature DB >> 24279908

Risk for transmission of Naegleria fowleri from solid organ transplantation.

S L Roy1, R Metzger, J G Chen, F R Laham, M Martin, S W Kipper, L E Smith, G M Lyon, J Haffner, J E Ross, A K Rye, W Johnson, D Bodager, M Friedman, D J Walsh, C Collins, B Inman, B J Davis, T Robinson, C Paddock, S R Zaki, M Kuehnert, A DaSilva, Y Qvarnstrom, R Sriram, G S Visvesvara.   

Abstract

Primary amebic meningoencephalitis (PAM) caused by the free-living ameba (FLA) Naegleria fowleri is a rare but rapidly fatal disease of the central nervous system (CNS) affecting predominantly young, previously healthy persons. No effective chemotherapeutic prophylaxis or treatment has been identified. Recently, three transplant-associated clusters of encephalitis caused by another FLA, Balamuthia mandrillaris, have occurred, prompting questions regarding the suitability of extra-CNS solid organ transplantation from donors with PAM. During 1995-2012, 21 transplant recipients of solid organs donated by five patients with fatal cases of PAM were reported in the United States. None of the recipients developed PAM, and several recipients tested negative for N. fowleri by serology. However, historical PAM case reports and animal experiments with N. fowleri, combined with new postmortem findings from four patients with PAM, suggest that extra-CNS dissemination of N. fowleri can occur and might pose a risk for disease transmission via transplantation. The risks of transplantation with an organ possibly harboring N. fowleri should be carefully weighed for each individual recipient against the potentially greater risk of delaying transplantation while waiting for another suitable organ. In this article, we present a case series and review existing data to inform such risk assessments. © Copyright 2013 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Keywords:  Ameba; Naegleria; amoeba; disseminated; primary amebic meningoencephalitis; transplant

Mesh:

Year:  2013        PMID: 24279908      PMCID: PMC4676565          DOI: 10.1111/ajt.12536

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  24 in total

1.  The role of blood vessels and lungs in the dissemination of Naegleria fowleri following intranasal inoculation in mice.

Authors:  Kirby L Jaroli; Jeffrey K McCosh; Marsha J Howard
Journal:  Folia Parasitol (Praha)       Date:  2002       Impact factor: 2.122

Review 2.  Primary amoebic meningoencephalitis.

Authors:  R J Duma
Journal:  CRC Crit Rev Clin Lab Sci       Date:  1972-06

3.  Primary amebic meningoencephalitis.

Authors:  R J Duma; H W Ferrell; E C Nelson; M M Jones
Journal:  N Engl J Med       Date:  1969-12-11       Impact factor: 91.245

4.  Successful treatment of primary amebic meningoencephalitis.

Authors:  J S Seidel; P Harmatz; G S Visvesvara; A Cohen; J Edwards; J Turner
Journal:  N Engl J Med       Date:  1982-02-11       Impact factor: 91.245

5.  Resistance of pathogenic Naegleria to some common physical and chemical agents.

Authors:  S L Chang
Journal:  Appl Environ Microbiol       Date:  1978-02       Impact factor: 4.792

6.  The pathogenicity of soil amebas.

Authors:  C G Culbertson
Journal:  Annu Rev Microbiol       Date:  1971       Impact factor: 15.500

7.  Description of a Naegleria sp. isolated from two cases of primary amoebic meningo-encephalitis, and of the experimental pathological changes induced by it.

Authors:  R F Carter
Journal:  J Pathol       Date:  1970-04       Impact factor: 7.996

8.  The pathogenicity of a Philippine isolate of Naegleria sp. in mice: effects of dose levels and routes of infection.

Authors:  E C Simeon; F F Natividad; G L Enriquez
Journal:  Southeast Asian J Trop Med Public Health       Date:  1990-12       Impact factor: 0.267

9.  Production of monoclonal antibodies to Naegleria fowleri, agent of primary amebic meningoencephalitis.

Authors:  G S Visvesvara; M J Peralta; F H Brandt; M Wilson; C Aloisio; E Franko
Journal:  J Clin Microbiol       Date:  1987-09       Impact factor: 5.948

10.  Experimental pneumonitis induced by Naegleria fowleri in mice.

Authors:  E Willaert; A R Stevens
Journal:  Trans R Soc Trop Med Hyg       Date:  1980       Impact factor: 2.184

View more
  6 in total

Review 1.  Brain-Eating Amoebae: Predilection Sites in the Brain and Disease Outcome.

Authors:  Timothy Yu Yee Ong; Naveed Ahmed Khan; Ruqaiyyah Siddiqui
Journal:  J Clin Microbiol       Date:  2017-04-12       Impact factor: 5.948

2.  Diagnosing Balamuthia mandrillaris encephalitis via next-generation sequencing in a 13-year-old girl.

Authors:  Xia Wu; Gangfeng Yan; Shuzhen Han; Yingzi Ye; Xunjia Cheng; Hairong Gong; Hui Yu
Journal:  Emerg Microbes Infect       Date:  2020-12       Impact factor: 7.163

3.  A pediatric case of primary amoebic meningoencephalitis due to Naegleria fowleri diagnosed by next-generation sequencing of cerebrospinal fluid and blood samples.

Authors:  Shiqin Huang; Xiu'an Liang; Yunli Han; Yanyan Zhang; Xinhui Li; Zhiyong Yang
Journal:  BMC Infect Dis       Date:  2021-12-14       Impact factor: 3.090

4.  Case Report and Literature Review: Bacterial Meningoencephalitis or Not? Naegleria fowleri Related Primary Amoebic Meningoencephalitis in China.

Authors:  Wenjuan Zhou; Yuzhen Ouyang; Di Zhang; Sheng Liao; Hui Liang; Lingling Zhao; Chunyuan Chen
Journal:  Front Pediatr       Date:  2022-04-08       Impact factor: 3.569

Review 5.  Mechanisms and management of drug-induced hyperkalemia in kidney transplant patients.

Authors:  John G Rizk; Jose G Lazo; David Quan; Steven Gabardi; Youssef Rizk; Elani Streja; Csaba P Kovesdy; Kamyar Kalantar-Zadeh
Journal:  Rev Endocr Metab Disord       Date:  2021-07-22       Impact factor: 6.514

Review 6.  Drugs used for the treatment of cerebral and disseminated infections caused by free-living amoebae.

Authors:  Alexandre Taravaud; Zineb Fechtali-Moute; Philippe M Loiseau; Sébastien Pomel
Journal:  Clin Transl Sci       Date:  2021-03-01       Impact factor: 4.689

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.